AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Analyst ratings
61%
of 31 ratingsMore ABBV News
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Health Canada's recent approval of ELAHERE® for a challenging form of cancer marks a step forward for in oncology, enhancing its presence in a high-need therape...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
AbbVie (NYSE:ABBV) on Wednesday released new data from a mid-stage trial designed to evaluate how its lymphoma therapy epcoritamab, marketed with Genmab (GMAB),...
AbbVie (ABBV) announced updated results from the Phase 2 EPCORE NHL-6 trial, or NCT05451810, evaluating the feasibility of dosing and monitoring patients in the...
Healthcare AbbVie's Elahere gains approval in Canada for ovarian cancer Sep. 02, 2025 2:01 PM ET AbbVie Inc. (ABBV) Stock By: Jonathan Block, SA News Editor 5 S...
